Dermapharm Holding SE annual operating margin
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Dermapharm Holding SE's operating margin was 18.94% for fiscal 2025.
View full Dermapharm Holding SE company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 18.94% | +0.57 pp |
| 2024 | 2024-12-31 | 18.37% | +2.26 pp |
| 2023 | 2023-12-31 | 16.11% | −7.67 pp |
| 2022 | 2022-12-31 | 23.78% | −7.87 pp |
| 2021 | 2021-12-31 | 31.65% | +14.41 pp |
| 2020 | 2020-12-31 | 17.24% | +0.19 pp |
| 2019 | 2019-12-31 | 17.05% | −1.73 pp |
| 2018 | 2018-12-31 | 18.78% | −0.94 pp |
| 2017 | 2017-12-31 | 19.72% | +0.19 pp |
| 2016 | 2016-12-31 | 19.53% | +3.74 pp |
| 2015 | 2015-12-31 | 15.79% | +4.73 pp |
| 2014 | 2014-12-31 | 11.05% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 24.92% | +8.57 pp |
| Q1 2026 | 2026-03-31 | 23.11% | +3.34 pp |
| Q4 2025 | 2025-12-31 | 19.69% | — |
| Q3 2025 | 2025-09-30 | 21.99% | — |
| Q2 2025 | 2025-06-30 | 16.35% | — |
| Q1 2025 | 2025-03-31 | 19.77% | — |
Over the last five fiscal years, Dermapharm Holding SE's operating margin increased from 17.24% to 18.94%, a change of +1.70 percentage points. The latest reported quarter, Q2 2026, shows 24.92%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as reported operating income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dermapharm Holding SE source filings ↗